Scientists set to scoop £150m in biotech deal: Now Oxford Nanopore joins London listing frenzy By Matt Oliver For The Daily Mail Published: 22:17 BST, 30 March 2021 | Updated: 22:17 BST, 30 March 2021 A trio of British scientists are set for a huge payday after their biotech firm unveiled plans for a blockbuster … Read more
Disgraced fund manager Neil Woodford is planning a shock comeback 18 months after his previous solo venture imploded leaving investors with huge losses. In his first interview since the collapse of Woodford Investment Management in October 2019, the fallen star of the fund management industry said he planned to launch a new Jersey-based fund focused … Read more
Neil Woodford plots shock comeback with new Jersey-based biotech fund – but it won’t be taking small investors’ money Neil Woodford’s £3billion Equity Income fund collapsed in October 2019 Savers had been locked out of their investments as increasing numbers attempted to pull their money out He is now planning to create a new fund … Read more
Blow to City as leading British biotech firm Immunocore reveals plans to float in New York By Matt Oliver For The Daily Mail Published: 21:50 GMT, 18 January 2021 | Updated: 21:50 GMT, 18 January 2021 A leading British biotechnology company has revealed plans to float in New York instead of London, dealing a blow … Read more
The stock market turbulence triggered by Covid may have battered the FTSE 100 last year – but new figures show London’s junior market managed to thrive. The AIM All-Share index rose 21 per cent in 2020, ending the year at 1157.04, up from 958.26 at the end of 2019. The blue-chip index, in contrast, fell … Read more
Chinese Nationals Li Xiaoyu (above), 34, and Dong Jiazhi, 31, allegedly stole ‘hundreds of millions of dollars’ worth of trade secrets, intellectual property, and other valuable business information’ in a sophisticated, decade-long scheme A British biotech company was hacked by two Chinese nationals linked to Beijing who have been charged int he US with stealing … Read more
A resurgence in Britain’s small-cap biotech sector has been one of the few good things to come out of the coronavirus pandemic. As governments have hunted for vaccines, diagnostic tools and treatments, the speed and flexibility of the UK’s smaller biotech constituents has been increasingly recognised, funding for companies become more easily available and the … Read more
Fresh hope for Woodford investors? US firm reportedly closing in on a deal to snap-up his stricken fund’s biotech holdings as one-year anniversary of its closure passes US-based Acacia Research Corporation is reportedly close to snapping up Neil Woodford’s biotech portfolio for just over $300m, according to Sky News Today marks one year since the … Read more
A California biotech company claims it has made a nearly 100 percent accurate coronavirus antibody test that screens for the immune cells using just a drop of dried blood from a finger prick. Enable Biosciences used the test on 31 people who had recovered after testing positive for coronavirus and compared their results to those … Read more
‘There is a cure’: California biotech company claims it has discovered an antibody that can block ‘100%’ of coronavirus infections Sorrento Therapeutics of California is set to announce that it has discovered an antibody that can completely block coronavirus Scientists with the company are calling it a ‘cure’ and say the antibody could be used … Read more